5 pending office actions • 4 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Peptinovo Biopharma, Inc. | 2 |
| Optique Debt Investment, LLC | 1 |
| Peptinovo Biopharma, Inc. | 1 |
| Michigan Technological University | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19204171 | CHEMOTHERAPEUTIC PACLITAXEL BASED MICELLULAR NANOPARTICLES | Peptinovo Biopharma, Inc. | ESPINOSA, CLAUDIA EDILMA | 1654 | Non-Final OA | May 09, 2025 |
| 18758379 | HYBRID REFLECTIVE/REFRACTIVE HEAD MOUNTED DISPLAY | Optique Debt Investment, LLC | SCHNIREL, ANDREW B | 2625 | Non-Final OA | Jun 28, 2024 |
| 18041289 | PEPTIDES AND FORMULATIONS FOR CANCER TREATMENT | Peptinovo Biopharma, Inc. | NIEBAUER, RONALD T | 1658 | Non-Final OA | Feb 10, 2023 |
| 17637018 | HIGH-BRIGHTNESS FLUOROPHORES FOR QUANTIFICATION AND PHENOTYPING OF EXTRACELLULAR VESICLES | Michigan Technological University | EVANS, CHRISTOPHER RYAN | 1677 | Non-Final OA | Feb 21, 2022 |
| 17634975 | PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER | Peptinovo Biopharma, Inc. | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Feb 12, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial